Types of change in coronary stenosis severity and their relative importance in overall progression and regression of coronary disease. Observations from the FATS Trial. Familial Atherosclerosis Treatment Study

Ann N Y Acad Sci. 1995 Jan 17:748:407-17; discussion 417-8. doi: 10.1111/j.1749-6632.1994.tb17337.x.

Authors

B G Brown¹, L Hillger, X Q Zhao, D Poulin, J J Albers

Affiliation

¹ Department of Medicine, University of Washington School of Medicine, Seattle.

PMID: 7695184
DOI: 10.1111/j.1749-6632.1994.tb17337.x

No abstract available

Publication types

Clinical Trial
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.

MeSH terms

Adult
Colestipol / therapeutic use
Coronary Disease / genetics*
Coronary Disease / pathology
Coronary Disease / therapy
Diet, Fat-Restricted
Humans
Lovastatin / therapeutic use
Male
Middle Aged
Niacin / therapeutic use

Substances

Niacin
Lovastatin
Colestipol

Grants and funding

etc